TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
CING

Cingulate Inc

Healthcare · Biotechnology

4.80$ -0.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CING
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
18.5% 30.9% 82.5% 69.0% 16.6% 85.2% 79.7%
7.9% 20.7% 72.1% 47.0% 1.5% 82.2% 72.7%
8.3% 20.7% 72.1% 47.0% 1.5% 82.2% 72.7%
2.1% 2.6% 3.0% 2.1% 0.4% 0.2% 0.1%
– – -3.0% 0.9% -0.4% -0.4% –
78.8% 69.1% 17.5% 31.0% – – –
88.3% 77.7% 8.9% 66.0% 296.8% 49.8% 83.4%
55.9% 58.1% 5.1% 61.5% 292.9% 33.4% 68.4%
7.1% 16.2% 1.4% 47.0% 96.7% 17.9% 43.4%
35.9% 16.8% 1.2% 6.7% 148.9% 8.5% 13.5%
– – – – – 16.4% 7.6%
11.7% 22.3% 91.1% 34.0% -196.8% 50.2% 16.6%
– -536.0% -226.0% -608.6% -2,662.0% -729.9% -878.2%
26.8% 24.4% 6.2% 12.4% 64.8% 25.6% 36.0%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?